Simrina K. Sabharwal, MBBS

Simrina Sabharwal practices at Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services.

Simrina Sabharwal's NPI, 1679001010, was assigned on May 30, 2017. Simrina Sabharwal holds Maine license MD27530.

Simrina Sabharwal's primary practice is Central Maine Medical Center, at 300 Main Street, Lewiston, ME 04240 in Androscoggin County. The practice phone is (207) 795-0111.

Simrina Sabharwal's primary practice is Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services. Simrina Sabharwal is also affiliated with MaineHealth Stephens Hospital. The medical group on file is Central Maine Medical Center. Dmand AI also links Simrina Sabharwal to 3 more hospitals and 1 group practice or clinic, each named with a free account. Simrina Sabharwal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Simrina Sabharwal practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Simrina Sabharwal's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Simrina Sabharwal is licensed in Maine.

CMS data shows 260 Medicare services from Simrina Sabharwal across 9 procedure codes in 2024, for 123 Medicare patients. Medicare paid $16,004 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Simrina Sabharwal in 2024. The largest group is 75 to 84, with 46 patients. 65% of them have copd, and 65% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Simrina Sabharwal's median patient age at 71, with 55% women.

In 2024, Simrina Sabharwal wrote 1,224 Medicare Part D claims for 295 patients. 57% of them were for generic drugs. CMS names the drug for 1,047 of them, across 23 drugs with 11 or more claims each, at $451,674 in total drug cost. In 2023, CMS named 181 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Simrina Sabharwal for performance year 2024, reported as part of a group. Simrina Sabharwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Simrina Sabharwal as offering telehealth.

CMS Open Payments shows 1 general payment to Simrina Sabharwal from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Verona Pharma, Inc. paid the most, $15.